Patents by Inventor Adnan Ahmad ANSARI

Adnan Ahmad ANSARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230084335
    Abstract: Provided are an analytical method of providing an information for diagnosis of a patient who exhibits a response to preoperative chemoradiotherapy in a rectal cancer patient, wherein the expression levels of nine genes, i.e., FGFR3, GNA11, H3F3A, IL12A, IL1R1, IL2RB, NKD1, SGK2, and SPRY2 genes, is analyzed in combination, in carcinoma tissues of a rectal cancer patient, the response (susceptibility) to preoperative chemoradiotherapy can be predicted with high accuracy, and therefore the combination of said genes can be usefully applied as a biomarker for selecting a rectal cancer patient who exhibits a response to preoperative chemoradiotherapy.
    Type: Application
    Filed: February 8, 2021
    Publication date: March 16, 2023
    Applicants: THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION, CBSBIOSCIENCE CO., LTD
    Inventors: Chang-Sik YU, In-Ja PARK, Seung-Mo HONG, Sung-Min AHN, Adnan Ahmad ANSARI, Bilal MUSTAFA, Jin-Young PARK